UB Paderborn / Katalog / Suche / in CDI

Sympathetic activation in heart failure

European heart journal supplements, 2022-08, Vol.24 (Supplement_E), p.E4-E11

2022

Link zum Volltext

Verfügbarkeit prüfen

Cryoballoon ablation for atrial fibrillation guided by real-time three-dimensional transoesophageal echocardiography: a feasibility study

Europace (London, England), 2013-07, Vol.15 (7), p.944-950

2013

Link zum Volltext

Verfügbarkeit prüfen

8B.02: EFFECTS OF LONG-TERM BAROREFLEX ACTIVATION IN CONGESTIVE HEART FAILURE

Journal of hypertension, 2015-06, Vol.33 Suppl 1 - ESH 2015 Abstract Book (Supplement 1), p.e107-e107

2015

Link zum Volltext

Verfügbarkeit prüfen

P471 CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN THERAPY WITH SGLT2I RELATED TO THE HEART FAILURE OUTPATIENT

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D228-D228

2023

Link zum Volltext

Verfügbarkeit prüfen

Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

The Journal of heart and lung transplantation, 2006-09, Vol.25 (9), p.1043-1056

2006

Link zum Volltext

Verfügbarkeit prüfen

P331 ANALYSIS OF THE CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS ADMITTED TO THE HEART FAILURE CLINIC IN THE PERIOD APRIL–SEPTEMBER 2022. ORGANIZED BY THE ANMCO AREA CARDIO RENO METABOLICA

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D174-D174

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

Heart (British Cardiac Society), 2003-03, Vol.89 (3), p.299-305

2003

Link zum Volltext

Verfügbarkeit prüfen

P473 SURVEY ON THE USE OF SGLT2I THERAPY: CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN A GROUP OF CENTERS IN PUGLIA, MOLISE AND ABRUZZO. ANMCO CARDIO RENO METABOLIC AREA

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D229-D229

2023

Link zum Volltext

Verfügbarkeit prüfen

P469 UP TO 12 MONTH TRENDS IN CLINICAL AND BIOCHEMICAL PARAMETERS AFTER SGLT2I THERAPY IN PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D227-D227

2023

Link zum Volltext

Verfügbarkeit prüfen

Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation

European heart journal, 2001-06, Vol.22 (11), p.964-971

2001

Link zum Volltext

Verfügbarkeit prüfen

P468 CLINICAL CHARACTERISTICS OF PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND UNDERGOING SGLT2I THERAPY

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D227-D227

2023

Link zum Volltext

Verfügbarkeit prüfen

[BP.10.04] NORMALIZATION OF SYMPATHETIC NERVE TRAFFIC IN THE LONG TERM FOLLOW-UP AFTER BAROREFLEX ACTIVATION THERAPY IN HEART FAILURE PATIENTS: FINAL STUDY REPORT

Journal of hypertension, 2017-09, Vol.35 (Supplement 2), p.e346

2017

Link zum Volltext

Verfügbarkeit prüfen

P2592Combining home monitoring temporal trends and baseline patient risk profile for predicting impending heart failure hospitalizations. Results from the SELENE HF (BIO.Detect HF IV) study

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study

European journal of cardio-thoracic surgery, 1999-06, Vol.15 (6), p.835-841

1999

Link zum Volltext

Verfügbarkeit prüfen

Baroflex Activation Therapy for Refractory Congestive Heart Failure: Anesthetic Implications

Journal of cardiothoracic and vascular anesthesia, 2017-06, Vol.31 (3), p.1103-1108

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support

The Journal of heart and lung transplantation, 1999-07, Vol.18 (7), p.654-663

1999

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation

The Journal of heart and lung transplantation, 1997-04, Vol.16 (4), p.460-463

1997

Link zum Volltext

Verfügbarkeit prüfen

Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure

The Journal of heart and lung transplantation, 1997-02, Vol.16 (2), p.160-168

1997

Link zum Volltext

Verfügbarkeit prüfen

Renal function and mortality in patients with chronic heart failure treated with resynchronization therapy

European heart journal, 2013-08, Vol.34 (suppl 1), p.P3157-P3157

2013

Link zum Volltext

Verfügbarkeit prüfen

The International Society for Heart and Lung Transplantation: a focus on our mission

The Journal of heart and lung transplantation, 1998-04, Vol.17 (4), p.333-334

1998

Link zum Volltext

Verfügbarkeit prüfen

Relapsing Aspergillus Bronchitis in a Double Lung Transplant Patient, Successfully Treated With a New Oral Antimycotic Agent

Chest, 1997-03, Vol.111 (3), p.835-836

1997

Link zum Volltext

Verfügbarkeit prüfen

Mechanical circulatory support for advanced heart failure : Effect of patient selection on outcome

Circulation (New York, N.Y.), 2001-01, Vol.103 (2), p.231-237

2001

Link zum Volltext

Verfügbarkeit prüfen

Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation

British journal of haematology, 2004-07, Vol.126 (1), p.85-92

2004

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Sympathetic activation in heart failure

Cryoballoon ablation for atrial fibrillation guided by real-time three-dimensional transoesophageal echocardiography: a feasibility study

8B.02: EFFECTS OF LONG-TERM BAROREFLEX ACTIVATION IN CONGESTIVE HEART FAILURE

P471 CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN THERAPY WITH SGLT2I RELATED TO THE HEART FAILURE OUTPATIENT

Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

P331 ANALYSIS OF THE CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS ADMITTED TO THE HEART FAILURE CLINIC IN THE PERIOD APRIL–SEPTEMBER 2022. ORGANIZED BY THE ANMCO AREA CARDIO RENO METABOLICA

Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

P473 SURVEY ON THE USE OF SGLT2I THERAPY: CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN A GROUP OF CENTERS IN PUGLIA, MOLISE AND ABRUZZO. ANMCO CARDIO RENO METABOLIC AREA

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study

P469 UP TO 12 MONTH TRENDS IN CLINICAL AND BIOCHEMICAL PARAMETERS AFTER SGLT2I THERAPY IN PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

Sympathetic Response and Outcomes Following Renal Denervation in Patients with Chronic Heart Failure: 12-Month Outcomes From the SYMPLICITY HF Feasibility Study

Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation

P468 CLINICAL CHARACTERISTICS OF PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND UNDERGOING SGLT2I THERAPY

[BP.10.04] NORMALIZATION OF SYMPATHETIC NERVE TRAFFIC IN THE LONG TERM FOLLOW-UP AFTER BAROREFLEX ACTIVATION THERAPY IN HEART FAILURE PATIENTS: FINAL STUDY REPORT

P2592Combining home monitoring temporal trends and baseline patient risk profile for predicting impending heart failure hospitalizations. Results from the SELENE HF (BIO.Detect HF IV) study

The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study

Baroflex Activation Therapy for Refractory Congestive Heart Failure: Anesthetic Implications

Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support

Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation

Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure

Renal function and mortality in patients with chronic heart failure treated with resynchronization therapy

The International Society for Heart and Lung Transplantation: a focus on our mission

Relapsing Aspergillus Bronchitis in a Double Lung Transplant Patient, Successfully Treated With a New Oral Antimycotic Agent

Mechanical circulatory support for advanced heart failure : Effect of patient selection on outcome

Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation

Suchergebnisse filtern